Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 10, 2012, Pages 1802-1810

  Zhuo, Lang ^a   Liao, Ming ^a   Zheng, Li ^a   He, Min ^a   Huang, Quanfang ^a   Wei, Ling ^a   Huang, Renbin ^a   Zhang, Shijun ^a   Lin, Xing ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Combination therapy; Epigallocatechin gallate; Genistein; Liver fibrosis; Taurine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; COLCHICINE; COLLAGEN; EPIGALLOCATECHIN GALLATE; GAMMA GLUTAMYLTRANSFERASE; GENISTEIN; HYDROXYPROLINE; INTERLEUKIN 6; PROTEIN BCL 2; SMAD3 PROTEIN; SODIUM CHLORIDE; TAURINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER FUNCTION; LIVER PROTECTION; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ACTINS; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CATECHIN; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ETHANOL; GAMMA-GLUTAMYLTRANSFERASE; GENISTEIN; LIVER CIRRHOSIS; PEROXIDASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA, MESSENGER; SMAD3 PROTEIN; TAURINE;

EID: 84867241746     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00548     Document Type: Article

References (37)

1. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C. Worldwide mortality from cirrhosis: an update to 2002. J. Hepatol., 46, 827-839 (2007).
2. Karsan HA, Rojter SE, Saab S. Primary prevention of cirrhosis. Public health strategies that can make a difference. Postgrad. Med., 115, 25-30 (2004).
3. Mishra A, Paul S, Swarnakar S. Downregulation of matrix metalloproteinase-9 by melatonin during prevention of alcohol-induced liver injury in mice. Biochimie, 93, 854-866 (2011).
4. Safadi R, Friedman SL. Hepatic fibrosis - role of hepatic stellate cell activation. MedGenMed, 4, 27 (2002).
5. Bonis PAL, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N. Engl. J. Med., 344, 452-454 (2001).
6. Geramizadeh B, Janfeshan K, Saberfiroozi M. Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B. Saudi Journal of Gastroenterology, 14, 174 (2008).
7. Chen YX, Zhang XR, Xie WF, Li S. Effects of taurine on proliferation and apoptosis of hepatic stellate cells in vitro. HBPD INT, 3, 106-109 (2004).
8. Kato J, Ido A, Hasuike S, Uto H, Hori T, Hayashi K, Murakami S, Terano A, Tsubouchi H. Transforming growth factor-β-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis. Hepatol. Res., 30, 34-41 (2004).
9. Miyazaki T, Karube M, Matsuzaki Y, Ikegami T, Doy M, Tanaka N, Bouscarel B. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J. Hepatol., 43, 117-125 (2005).
10. Nakamuta M, Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Kobayashi N, Enjoji M. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. Int. J. Mol. Med., 16, 677-681 (2005).
11. Liu X, Huang M, Cheng N, Xiao W, Wang Y. Effects of genistein on the fenestrae, proliferation and nitric oxide synthesis of liver sinusoidal endothelial cells from carbon tetrachloride-induced experimental hepatic fibrosis rats. Chinese Journal of Hepatology, 10, 200-203 (2002).
12. Liao M, Lin X, Chen Zn, Li Y, Zhuo L. Effects of cocktail therapy on TGF-β1, COL I and COL III expression in liver fibrosis in rats. Shijie Huaren Xiaohua Zazhi, 18, 1867-1872 (2010).
13. Liao M, Li Y, Shu W, Zhuo L. Effect of cocktail therapy on cell proliferation and collagen I and TIMP-1 mRNA expression in rat hepatic stellate cells. Shijie Huaren Xiaohua Zazhi, 9, 932-936 (2010).
14. Liao M, Mo CF, Zhou Y, He M, Zhuo L. Alterations in fibrosis-related gene expression and proteomic expression profile in rat hepatic stellate cells exposed to the cocktail. Shijie Huaren Xiaohua Zazhi, 17, 1780-1784 (2011).
15. Schlesinger N, Schumacher R, Catton M, Maxwell L. Colchicine for acute gout. Cochrane Database Syst. Rev., 4, CD006190 (2006).
16. Nikolaidis N, Kountouras J, Giouleme O, Tzarou V, Chatzizisi O, Patsiaoura K, Papageorgiou A, Leontsini M, Eugenidis N, Zamboulis C. Colchicine treatment of liver fibrosis. Hepatogastroenterology, 53, 281-285 (2006).
17. Poo JL, Feldmann G, Moreau A, Gaudin C, Lebrec D. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J. Hepatol., 19, 90-94 (1993).
18. Zhang XH, Yan M, Liu L, Wu TJ, Ma LL, Wang LX. Expression of discoidin domain receptors (DDR2) in alcoholic liver fibrosis in rats. Arch. Med. Res., 41, 586-592 (2010).
19. Zeraik ML, Serteyn D, Deby-Dupont G, Wauters JN, Tits M, Yariwake JH, Angenot L, Franck T. Evaluation of the antioxidant activity of passion fruit (Passiflora edulis and P. alata) extracts on stimulated neutrophils and myeloperoxidase activity assays. Food Chem., 128, 259-265 (2011).
20. Shaker ME, Salem HA, Shiha GE, Ibrahim TM. Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression. Fundam. Clin. Pharmacol., 25, 248-257 (2011).
21. Lee TY, Chang HH, Chen JH, Hsueh ML, Kuo JJ. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J. Ethnopharmacol., 109, 318-324 (2007).
22. Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, Xu W, Wu M, Yin Z. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J. Ethnopharmacol., 137, 714-723 (2011).
23. Oh SW, Kim DH, Ha JR, Kim DY. Anti-fibrotic effects of a methylenedioxybenzene compound, CW209292 on dimethylni-trosamine- induced hepatic fibrosis in rats. Biol. Pharm. Bull., 32, 1364-1370 (2009).
24. Takahashi M, Satake N, Yamashita H, Tamura A, Sasaki M, Matsui-Yuasa I, Tabuchi M, Akahoshi Y, Terada M, Kojima-Yuasa A. Ecklonia cava polyphenol protects the liver against ethanol-induced injury in rats. Biochimica et Biophysica Acta (BBA)-General Subjects, 1820, 978-988 (2012).
25. Lieber CS. Alcohol and the liver: metabolism of alcohol and its role in hepatic and extrahepatic diseases. Mt. Sinai J. Med., 67, 84-94 (2000).
26. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A. Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology, 31, 101-108 (2000).
27. Devaraj S, Ismail S, Ramanathan S, Marimuthu S, Mun Y. Evaluation of the hepatoprotective activity of standardized ethanolic extract of Curcuma xanthorrhiza Roxb. J. Med. Plant. Res, 4, 2512-2517 (2010).
28. Dahiru D, Obidoa O. Evaluation of the antioxidant effects of Ziziphus mauritiana LAM. Leaf extracts against chronic ethanol-induced hepatotoxicity in rat liver. Afr. J. Tradit. Complement. Altern. Medicines, 5, 39-45 (2007).
29. Hoek JB, Pastorino JG. Cellular signaling mechanisms in alcohol-induced liver damage. Semin. Liver Dis., 24, 257-272 (2004).
30. Erdamar H, Türközkan N, Ekremoǧlu M, Kurt Y, Yaman H. The effect of taurine on polymorphonuclear leukocyte functions in endotoxemia. Amino Acids, 33, 581-585 (2007).
31. Lieber CS. Ethanol metabolism, cirrhosis and alcoholism. Clin. Chim. Acta, 257, 59-84 (1997).
32. Shyu MH, Kao TC, Yen GC. Hsian-tsao (Mesona procumbens HEML.) prevents against rat liver fibrosis induced by CCl4 via inhibition of hepatic stellate cells activation. Food Chem. Toxicol., 46, 3707-3713 (2008).
33. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J. Cell. Mol. Med., 10, 76-99 (2006).
34. Shek FW, Benyon RC. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur. J. Gastroenterol. Hepatol., 16, 123-126 (2004).
35. Itoh S, ten Dijke P. Negative regulation of TGF-β receptor/Smad signal transduction. Curr. Opin. Cell Biol., 19, 176-184 (2007).
36. Wicks SJ, Grocott T, Haros K, Maillard M, ten Dijke P, Chantry A. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway. Biochem. Soc. Trans., 34, 761-763 (2006).
37. Kirshenbaum LA, de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation, 96, 1580-1585 (1997).